8 min

Building a Better Antibody Lab in the Time of Coronavirus

    • Life Sciences

Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.


 


In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19. 

Meet a protein aficionado working on a new way to treat COVID-19. As an expert on proteins, biochemist Barry Honig, PhD, has explored a huge variety of topics during his career: from color vision to cancer. He’s a theorist, a scientist interested in understanding general principles of how proteins interact and how those principles carry over from one problem to the next.


 


In this episode, explore how Dr. Honig is applying lessons learned from studying brain cells to the treatment of coronavirus. He and his colleagues recently received a grant to build better antibodies that block viruses from penetrating human cells. Inspired by previous works on AIDS, such antibodies could provide a new way to combat COVID-19. 

8 min